Literature DB >> 33166951

Surviving Lambs with Myelomeningocele Repaired in utero with Placental Mesenchymal Stromal Cells for 6 Months: A Pilot Study.

Kaeli Yamashiro1, Laura A Galganski2, Jamie Peyton3, Kalie Haynes3, Victoria Vicuna3, Priyadarsini Kumar2,4, Benjamin Keller2, James Becker2, Christopher Pivetti2,4, Sarah Stokes2, Christina Theodorou2, Jordan Jackson2, Aijun Wang2,4,5, Diana Farmer2,4.   

Abstract

BACKGROUND: Fetal repair of myelomeningocele (MMC) with placental mesenchymal stromal cells (PMSCs) rescues ambulation in the ovine model up to 48 h postnatally. Outcomes past 48 h are unknown as MMC lambs have not been survived past this timepoint.
OBJECTIVE: We aimed to survive lambs for 6 months following the fetal repair of MMC with PMSCs.
METHODS: Fetal MMC lambs were repaired with PMSCs. Lambs received either no additional treatment or postnatal bracing and physical therapy (B/PT). Motor function was assessed with the sheep locomotor rating (SLR). Lambs with an SLR of 15 at birth were survived for 6 months or until a decline in SLR less than 15, whichever came first. All lambs underwent a perimortem MRI.
RESULTS: The lambs with no postnatal treatment (n = 2) had SLR declines to 7 and 13 at 29 and 65 days, respectively, and were euthanized. These lambs had a spinal angulation of 57° and 47°, respectively. The B/PT lamb (n = 1) survived for 6 months with a sustained SLR of 15 and a lumbar angulation of 42°.
CONCLUSION: Postnatal physical therapy and bracing counteracted the inherent morbidity of the absent paraspinal muscles in the ovine MMC model allowing for survival and maintenance of rescued motor function of the prenatally treated lamb up to 6 months.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Fetal myelomeningocele repair; Fetal surgery; Placental mesenchymal stromal cells

Year:  2020        PMID: 33166951     DOI: 10.1159/000510813

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  5 in total

Review 1.  Dural substitutes for spina bifida repair: past, present, and future.

Authors:  Marcos M Miyabe; Kendall P Murphy; Marc Oria; Soner Duru; Chia-Ying Lin; Jose L Peiro
Journal:  Childs Nerv Syst       Date:  2022-04-04       Impact factor: 1.475

2.  Long-term safety evaluation of placental mesenchymal stromal cells for in utero repair of myelomeningocele in a novel ovine model.

Authors:  Sarah C Stokes; Christina M Theodorou; Jordan E Jackson; Christopher Pivetti; Priyadarsini Kumar; Kaeli J Yamashiro; Zachary J Paxton; Lizette Reynaga; Alicia Hyllen; Aijun Wang; Diana L Farmer
Journal:  J Pediatr Surg       Date:  2021-09-20       Impact factor: 2.549

3.  A Novel Model of Fetal Spinal Cord Exposure Allowing for Long-Term Postnatal Survival.

Authors:  Sarah C Stokes; Jordan E Jackson; Christina M Theodorou; Christopher D Pivetti; Priyadarsini Kumar; Kaeli J Yamashiro; Aijun Wang; Diana L Farmer
Journal:  Fetal Diagn Ther       Date:  2021-06-10       Impact factor: 2.208

4.  Efficacy of clinical-grade human placental mesenchymal stromal cells in fetal ovine myelomeningocele repair.

Authors:  Christina M Theodorou; Sarah C Stokes; Jordan E Jackson; Christopher D Pivetti; Priyadarsini Kumar; Kaeli J Yamashiro; Zachary J Paxton; Lizette Reynaga; Alicia A Hyllen; Aijun Wang; Diana L Farmer
Journal:  J Pediatr Surg       Date:  2021-06-05       Impact factor: 2.549

5.  Placental Mesenchymal Stromal Cells: Preclinical Safety Evaluation for Fetal Myelomeningocele Repair.

Authors:  Jordan E Jackson; Christopher Pivetti; Sarah C Stokes; Christina M Theodorou; Priyadarsini Kumar; Zachary J Paxton; Alicia Hyllen; Lizette Reynaga; Aijun Wang; Diana L Farmer
Journal:  J Surg Res       Date:  2021-07-15       Impact factor: 2.417

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.